Simplex Trading, LLC Aveo Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$6.61 - $8.72 $8,454 - $11,152	1,279 New	1,279 $10,000
Q2 2022 Aug 03, 2022	SELL	$3.51 - $6.67 $248,132 - $471,522	-70,693 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$3.15 - $6.01 $194,166 - $370,456	61,640 Added 680.88%	70,693 $395,000
Q4 2021 Feb 23, 2022	SELL	$4.69 - $7.4 $82,839 - $130,706	-17,663 Reduced 66.11%	9,053 $42,000
Q3 2021 Oct 28, 2021	BUY	$5.12 - $6.89 $138 - $186	27 Added 0.1%	26,716 $168,000
Q2 2021 Aug 12, 2021	BUY	$6.21 - $7.45 $68,527 - $82,210	11,035 Added 70.49%	26,689 $175,000
Q1 2021 Apr 26, 2021	BUY	$5.97 - $15.28 $93,454 - $239,193	15,654 New	15,654 $114,000

Ticker AVEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,676,000
Description
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.